US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

BridgeBio Pharma, Inc.

56.63

+0.13000.23%

Post-market: 55.58-1.0500-1.85%19:52 EDT

Volume:1.88M

Turnover:106.50M

Market Cap:10.83B

PE:-13.83

High:57.49

Open:56.63

Low:55.71

Close:56.50

52wk High:57.49

52wk Low:21.72

Shares:191.17M

Float Shares:151.20M

Volume Ratio:0.76

T/O Rate:1.24%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-4.0935

EPS(LYR):-2.8793

ROE:-1789.67%

ROA:-41.96%

PB:-6.06

PE(LYR):-19.67

Loading ...

Overview Company News Filings

BridgeBio Pharma Inc - Fortify Phase 3 Topline Results Expected Fall 2025

THOMSON REUTERS

BridgeBio Pharma Inc - Propel 3 Phase 3 Topline Results Expected Early 2026

THOMSON REUTERS

Corrected-BridgeBio Pharma Q2 Revenue USD 110.6 Million VS. Ibes Estimate USD 91.4 Million (Corrects Amount)

THOMSON REUTERS

Helix Acquisition Corp. II Conducted Extraordinary General Meeting

Biotech Has Been Stalling. 3 Stocks That Could See Healthy Gains. -- Barrons.com

BRIEF-Novel Human Genetics Evidence Confirms Estimates Of Genetic Prevalence, Underdiagnosis, And Potentially Greater Symptom Burden Of Gain-Of-Function CASR Variants Associated With ADH1

BridgeBio Pharma Announces Full Enrollment of Phase 3 Trial for Encaleret, Aiming to Address Underdiagnosed ADH1 Disorder

BridgeBio Pharma Inc. to Release Second Quarter 2025 Financial Results

Truist Securities Initiates Coverage on BridgeBio Pharma With Buy Rating, $66 Price Target

MT Newswires Live

BridgeBio Pharma Inc. Publishes Document on CLARIFY Study of ADH1/2 Disease Monitoring

BridgeBio Pharma Initiated at Buy by Jefferies

U.S. RESEARCH ROUNDUP-Best Buy, Chevron, SoundHound AI

BridgeBio Pharma Inc. Publishes Document on Phase 2/3 Study of Encaleret for Autosomal Dominant Hypocalcemia Type 1 in Pediatrics

BridgeBio Pharma Inc. Publishes Findings on Genetic Contributors of Non-Surgical Hypoparathyroidism

BridgeBio Pharma Is Maintained at Buy by Citigroup

BridgeBio Pharma May Keep Outperforming as Attruby Sales Beat Consensus, Oppenheimer Says

MT Newswires Live

BridgeBio Pharma CEO Neil Kumar Reports Disposal of Common Shares

BridgeBio Pharma Inc. Enters $300 Million Royalty Financing Agreement with Acoramidis Royalty SPV, LP and LSI Financing Fund, LP

Viking Global Investors LP Reports Disposal of Common Shares of BridgeBio Pharma Inc

Director Hannah Valantine Reports Disposal of Common Shares in BridgeBio Pharma Inc

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/BBIO/news?page=4"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BBIO","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BBIO\",,,,,undefined,":{"symbol":"BBIO","market":"US","secType":"STK","nameCN":"BridgeBio Pharma, Inc.","latestPrice":56.63,"timestamp":1760558400000,"preClose":56.5,"halted":0,"volume":1880975,"hourTrading":{"tag":"盘后","latestPrice":55.58,"preClose":56.63,"latestTime":"19:52 EDT","volume":340522,"amount":19283677.73,"timestamp":1760572334581},"delay":0,"floatShares":151204231,"shares":191168504,"eps":-4.093525,"marketStatus":"Not Yet Opened","change":0.13,"latestTime":"10-15 16:00:00 EDT","open":56.63,"high":57.49,"low":55.71,"amount":106499704.129625,"amplitude":0.031504,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-4.093525,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1760601600000},"marketStatusCode":0,"adr":0,"listingDate":1561608000000,"exchange":"NASDAQ","adjPreClose":56.5,"preHourTrading":{"tag":"盘前","latestPrice":56.5,"preClose":56.5,"latestTime":"09:29 EDT","volume":16422,"amount":925745.647848,"timestamp":1760534949254},"postHourTrading":{"tag":"盘后","latestPrice":55.58,"preClose":56.63,"latestTime":"19:52 EDT","volume":340522,"amount":19283677.73,"timestamp":1760572334581},"volumeRatio":0.760125,"impliedVol":0.7501,"impliedVolPercentile":0.812},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BBIO\",,,,,undefined,":{"symbol":"BBIO","floatShares":151204231,"roa":"-41.96%","roe":"-1789.67%","lyrEps":-2.879266,"volumeRatio":0.760125,"shares":191168504,"dividePrice":0,"high":57.49,"amplitude":0.031504,"preClose":56.5,"low":55.71,"week52Low":21.72,"pbRate":"-6.06","psRate":"45.91","week52High":57.49,"institutionHeld":0,"latestPrice":56.63,"eps":-4.093525,"divideRate":0,"volume":1880975,"delay":0,"ttmEps":-4.093525,"open":56.63,"prevYearClose":27.44,"prevWeekClose":55.49,"prevMonthClose":51.94,"prevQuarterClose":51.94,"fiveDayClose":55.3,"twentyDayClose":51.18,"sixtyDayClose":45.77},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/BBIO\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-08-05","symbol":"BBIO","fiscalQuarterEnding":"2025/06","expectedEps":-0.83,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1754366400000,"reportTimeType":"post","actualEps":-0.95},{"market":"US","date":"2025-04-29","symbol":"BBIO","fiscalQuarterEnding":"2025/03","expectedEps":1,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1745899200000,"reportTimeType":"post","actualEps":-0.88},{"market":"US","date":"2025-02-20","symbol":"BBIO","fiscalQuarterEnding":"2024/12","expectedEps":-1.09,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1740027600000,"reportTimeType":"pre","actualEps":-1.31},{"market":"US","date":"2024-11-12","symbol":"BBIO","fiscalQuarterEnding":"2024/09","expectedEps":-1.03,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1731387600000,"reportTimeType":"pre","actualEps":-0.86},{"market":"US","date":"2024-08-01","symbol":"BBIO","fiscalQuarterEnding":"2024/06","expectedEps":-1.09,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1722484800000,"reportTimeType":"pre","actualEps":-1.02}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"BBIO\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"BBIO\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.2778,"buy":0.7222,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.7222,"analysts":18,"updateTime":1753156800000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/BBIO\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"BBIO","date":"2025-10-14","current":-13.834043,"percent":0.219334,"low":-24.533016,"twenty":-14.205487,"median":-10.142902,"eighty":-3.273623,"high":-1.291392,"avg":-9.801269,"sd":5.433319,"marketCap":10697789483},"quantilePoints":[{"date":"2020-10-16","current":-14.496805,"twenty":-18.927326,"median":-14.219284,"eighty":-11.942526,"marketCap":5020562537},{"date":"2020-10-23","current":-14.033275,"twenty":-18.889011,"median":-14.123676,"eighty":-11.947309,"marketCap":4860031980},{"date":"2020-10-30","current":-13.580361,"twenty":-18.883538,"median":-14.058044,"eighty":-11.956547,"marketCap":4703177695},{"date":"2020-11-06","current":-11.999283,"twenty":-18.878064,"median":-14.054742,"eighty":-11.995815,"marketCap":4826123505},{"date":"2020-11-13","current":-13.262445,"twenty":-18.828803,"median":-14.033275,"eighty":-11.999283,"marketCap":5334168760},{"date":"2020-11-20","current":-13.478813,"twenty":-18.82333,"median":-13.991375,"eighty":-12.026486,"marketCap":5421192193},{"date":"2020-11-27","current":-14.972057,"twenty":-18.766405,"median":-14.022925,"eighty":-12.033153,"marketCap":6021776452},{"date":"2020-12-04","current":-15.904573,"twenty":-18.743416,"median":-14.051439,"eighty":-12.074825,"marketCap":6396835193},{"date":"2020-12-11","current":-18.696025,"twenty":-18.714954,"median":-14.088121,"eighty":-12.09832,"marketCap":7519560051},{"date":"2020-12-18","current":-19.774818,"twenty":-18.752525,"median":-14.139769,"eighty":-12.11487,"marketCap":7953451536},{"date":"2020-12-24","current":-21.179686,"twenty":-18.848507,"median":-14.160658,"eighty":-12.145667,"marketCap":8518491012},{"date":"2020-12-31","current":-21.670324,"twenty":-18.912,"median":-14.227887,"eighty":-12.164985,"marketCap":8715825839},{"date":"2021-01-08","current":-19.963759,"twenty":-19.014902,"median":-14.257579,"eighty":-12.188813,"marketCap":8029443830},{"date":"2021-01-15","current":-20.908464,"twenty":-19.101383,"median":-14.301767,"eighty":-12.227589,"marketCap":8409405299},{"date":"2021-01-22","current":-21.199057,"twenty":-19.153929,"median":-14.368324,"eighty":-12.247649,"marketCap":8526282041},{"date":"2021-01-29","current":-17.318055,"twenty":-19.153929,"median":-14.428476,"eighty":-12.309932,"marketCap":6965339215},{"date":"2021-02-05","current":-20.832925,"twenty":-19.169033,"median":-14.496805,"eighty":-12.366172,"marketCap":8379023284},{"date":"2021-02-12","current":-24.514819,"twenty":-19.240829,"median":-14.533758,"eighty":-12.38011,"marketCap":9859884665},{"date":"2021-02-19","current":-24.267341,"twenty":-19.393888,"median":-14.608054,"eighty":-12.401532,"marketCap":9760349012},{"date":"2021-02-26","current":-23.082259,"twenty":-19.68266,"median":-14.654314,"eighty":-12.426535,"marketCap":10357563680},{"date":"2021-03-05","current":-20.319442,"twenty":-19.823577,"median":-14.735677,"eighty":-12.434869,"marketCap":9117821338},{"date":"2021-03-12","current":-23.167168,"twenty":-19.963759,"median":-14.782839,"eighty":-12.472929,"marketCap":10395664509},{"date":"2021-03-19","current":-22.096005,"twenty":-20.073201,"median":-14.841966,"eighty":-12.485349,"marketCap":9915007903},{"date":"2021-03-26","current":-19.862238,"twenty":-20.115073,"median":-14.906468,"eighty":-12.491444,"marketCap":8912663031},{"date":"2021-04-01","current":-19.38544,"twenty":-20.115452,"median":-15.027333,"eighty":-12.515058,"marketCap":8698712225},{"date":"2021-04-09","current":-17.795024,"twenty":-20.106315,"median":-15.082555,"eighty":-12.565045,"marketCap":7985054399},{"date":"2021-04-16","current":-18.000766,"twenty":-20.079386,"median":-15.290504,"eighty":-12.599324,"marketCap":8077375637},{"date":"2021-04-23","current":-17.788493,"twenty":-20.044158,"median":-15.319812,"eighty":-12.605139,"marketCap":7982123566},{"date":"2021-04-30","current":-18.603351,"twenty":-20.019831,"median":-15.360367,"eighty":-12.635536,"marketCap":8347770201},{"date":"2021-05-07","current":-13.789937,"twenty":-20.010471,"median":-15.376486,"eighty":-12.643209,"marketCap":7170119357},{"date":"2021-05-14","current":-15.406372,"twenty":-19.984428,"median":-15.341143,"eighty":-12.662152,"marketCap":8010589313},{"date":"2021-05-21","current":-16.623722,"twenty":-19.966654,"median":-15.399488,"eighty":-12.666883,"marketCap":8643554253},{"date":"2021-05-28","current":-16.996966,"twenty":-19.882542,"median":-15.453641,"eighty":-12.671032,"marketCap":8837623692},{"date":"2021-06-04","current":-16.640949,"twenty":-19.853018,"median":-15.478579,"eighty":-12.685213,"marketCap":8652511304},{"date":"2021-06-11","current":-18.355001,"twenty":-19.83702,"median":-15.547805,"eighty":-12.695943,"marketCap":9543737883},{"date":"2021-06-18","current":-17.608513,"twenty":-19.826327,"median":-15.720083,"eighty":-12.70625,"marketCap":9155599004},{"date":"2021-06-25","current":-17.355855,"twenty":-19.798145,"median":-15.849241,"eighty":-12.735844,"marketCap":9024228922},{"date":"2021-07-02","current":-18.332032,"twenty":-19.777367,"median":-15.904573,"eighty":-12.761796,"marketCap":9531795148},{"date":"2021-07-09","current":-18.423908,"twenty":-19.765066,"median":-15.95692,"eighty":-12.777314,"marketCap":9579566087},{"date":"2021-07-16","current":-16.991224,"twenty":-19.723327,"median":-16.220389,"eighty":-12.794169,"marketCap":8834638009},{"date":"2021-07-23","current":-17.398922,"twenty":-19.661012,"median":-16.344741,"eighty":-12.805568,"marketCap":9046621550},{"date":"2021-07-30","current":-15.346079,"twenty":-19.606599,"median":-16.220389,"eighty":-12.814383,"marketCap":7979239634},{"date":"2021-08-06","current":-16.359477,"twenty":-19.514064,"median":-16.18189,"eighty":-12.819413,"marketCap":8102308897},{"date":"2021-08-13","current":-15.155951,"twenty":-19.413996,"median":-16.072735,"eighty":-12.846913,"marketCap":7506242549},{"date":"2021-08-20","current":-14.826343,"twenty":-19.396383,"median":-15.911433,"eighty":-12.877744,"marketCap":7342998248},{"date":"2021-08-27","current":-15.264813,"twenty":-19.390509,"median":-15.885226,"eighty":-12.87943,"marketCap":7560158098},{"date":"2021-09-03","current":-15.609541,"twenty":-19.381725,"median":-15.844422,"eighty":-12.892818,"marketCap":7730890670},{"date":"2021-09-10","current":-15.225502,"twenty":-19.362334,"median":-15.782487,"eighty":-12.91781,"marketCap":7540688594},{"date":"2021-09-17","current":-15.760738,"twenty":-19.298571,"median":-15.74041,"eighty":-12.954856,"marketCap":7805773377},{"date":"2021-09-24","current":-14.687242,"twenty":-19.261739,"median":-15.613092,"eighty":-12.963853,"marketCap":7274106157},{"date":"2021-10-01","current":-14.436255,"twenty":-19.249167,"median":-15.567921,"eighty":-12.97305,"marketCap":7149800864},{"date":"2021-10-08","current":-13.338568,"twenty":-19.240829,"median":-15.484501,"eighty":-13.008846,"marketCap":6606152411},{"date":"2021-10-15","current":-14.50883,"twenty":-19.223163,"median":-15.472285,"eighty":-13.010321,"marketCap":7185744563},{"date":"2021-10-22","current":-14.212484,"twenty":-19.209589,"median":-15.429341,"eighty":-13.026819,"marketCap":7038974458},{"date":"2021-10-29","current":-14.665221,"twenty":-19.182062,"median":-15.400607,"eighty":-13.07699,"marketCap":7263200057},{"date":"2021-11-05","current":-14.682487,"twenty":-19.169033,"median":-15.392604,"eighty":-13.110082,"marketCap":7860166663},{"date":"2021-11-12","current":-13.163935,"twenty":-19.157212,"median":-15.36702,"eighty":-13.11831,"marketCap":7047220624},{"date":"2021-11-19","current":-11.72602,"twenty":-19.156665,"median":-15.341143,"eighty":-13.026819,"marketCap":6277442766},{"date":"2021-11-26","current":-10.873719,"twenty":-19.154476,"median":-15.313196,"eighty":-12.990726,"marketCap":5821169083},{"date":"2021-12-03","current":-10.618028,"twenty":-19.151739,"median":-15.29719,"eighty":-12.909107,"marketCap":5684286978},{"date":"2021-12-10","current":-9.949934,"twenty":-19.124371,"median":-15.270861,"eighty":-12.826359,"marketCap":5326627285},{"date":"2021-12-17","current":-11.726583,"twenty":-19.118898,"median":-15.23911,"eighty":-12.790369,"marketCap":6277744216},{"date":"2021-12-23","current":-11.168436,"twenty":-19.083868,"median":-15.195263,"eighty":-12.709249,"marketCap":5978944198},{"date":"2021-12-31","current":-4.586153,"twenty":-19.070732,"median":-15.161189,"eighty":-12.671032,"marketCap":2455164678},{"date":"2022-01-07","current":-4.028006,"twenty":-19.0565,"median":-15.154439,"eighty":-12.635536,"marketCap":2156364660},{"date":"2022-01-14","current":-3.505602,"twenty":-19.048838,"median":-15.122688,"eighty":-12.515058,"marketCap":1876699619},{"date":"2022-01-21","current":-2.831977,"twenty":-19.029609,"median":-15.09041,"eighty":-12.457705,"marketCap":1516078908},{"date":"2022-01-28","current":-2.485541,"twenty":-18.9953,"median":-15.074503,"eighty":-12.370463,"marketCap":1330616828},{"date":"2022-02-04","current":-2.746742,"twenty":-18.971579,"median":-15.027333,"eighty":-12.230213,"marketCap":1470449348},{"date":"2022-02-11","current":-2.386559,"twenty":-18.96564,"median":-14.97631,"eighty":-12.111576,"marketCap":1277627662},{"date":"2022-02-18","current":-2.221589,"twenty":-18.952504,"median":-14.926132,"eighty":-12.015605,"marketCap":1189312386},{"date":"2022-02-25","current":-2.072926,"twenty":-18.937178,"median":-14.906468,"eighty":-11.951004,"marketCap":1166101778},{"date":"2022-03-04","current":-1.970592,"twenty":-18.912,"median":-14.885263,"eighty":-11.912854,"marketCap":1108534728},{"date":"2022-03-11","current":-2.251355,"twenty":-18.886822,"median":-14.87267,"eighty":-11.825033,"marketCap":1266475095},{"date":"2022-03-18","current":-2.923088,"twenty":-18.881348,"median":-14.833903,"eighty":-11.728443,"marketCap":1644351114},{"date":"2022-03-25","current":-2.71842,"twenty":-18.870701,"median":-14.801469,"eighty":-11.69159,"marketCap":1529217015},{"date":"2022-04-01","current":-2.846993,"twenty":-18.847315,"median":-14.776883,"eighty":-11.608067,"marketCap":1601544847},{"date":"2022-04-08","current":-2.870609,"twenty":-18.826614,"median":-14.735625,"eighty":-11.535084,"marketCap":1614829550},{"date":"2022-04-14","current":-2.881105,"twenty":-18.809449,"median":-14.718485,"eighty":-11.491836,"marketCap":1620733863},{"date":"2022-04-22","current":-2.629205,"twenty":-18.753576,"median":-14.690266,"eighty":-11.338723,"marketCap":1479030356},{"date":"2022-04-29","current":-2.105628,"twenty":-18.749985,"median":-14.681194,"eighty":-11.176698,"marketCap":1184497603},{"date":"2022-05-06","current":-1.660715,"twenty":-18.734659,"median":-14.654146,"eighty":-11.087543,"marketCap":989548848},{"date":"2022-05-13","current":-1.640886,"twenty":-18.706197,"median":-14.641584,"eighty":-11.009507,"marketCap":977733339},{"date":"2022-05-20","current":-1.886275,"twenty":-18.697156,"median":-14.5737,"eighty":-10.959651,"marketCap":1123950259},{"date":"2022-05-27","current":-1.794564,"twenty":-18.693024,"median":-14.524054,"eighty":-10.880079,"marketCap":1069303531},{"date":"2022-06-03","current":-1.789607,"twenty":-18.681019,"median":-14.50883,"eighty":-10.818731,"marketCap":1066349654},{"date":"2022-06-10","current":-1.650801,"twenty":-18.650314,"median":-14.476362,"eighty":-10.633999,"marketCap":983641094},{"date":"2022-06-17","current":-1.89619,"twenty":-18.648178,"median":-14.436255,"eighty":-10.550062,"marketCap":1129858013},{"date":"2022-06-24","current":-2.2903,"twenty":-18.647542,"median":-14.38433,"eighty":-10.458015,"marketCap":1364691247},{"date":"2022-07-01","current":-2.45885,"twenty":-18.64076,"median":-14.342591,"eighty":-10.337365,"marketCap":1465123071},{"date":"2022-07-08","current":-2.498509,"twenty":-18.63798,"median":-14.300413,"eighty":-10.289314,"marketCap":1488754088},{"date":"2022-07-15","current":-2.228333,"twenty":-18.62081,"median":-14.263271,"eighty":-10.199154,"marketCap":1327767783},{"date":"2022-07-22","current":-2.51586,"twenty":-18.605956,"median":-14.240772,"eighty":-10.029272,"marketCap":1499092658},{"date":"2022-07-29","current":-2.146537,"twenty":-18.593131,"median":-14.233652,"eighty":-9.951747,"marketCap":1279028810},{"date":"2022-08-05","current":-3.256753,"twenty":-18.574173,"median":-14.215884,"eighty":-9.132314,"marketCap":1658876197},{"date":"2022-08-12","current":-3.37608,"twenty":-18.553052,"median":-14.192196,"eighty":-4.665338,"marketCap":1719657184},{"date":"2022-08-19","current":-3.018099,"twenty":-18.523053,"median":-14.156478,"eighty":-4.072548,"marketCap":1537314224},{"date":"2022-08-26","current":-3.050114,"twenty":-18.46994,"median":-14.139769,"eighty":-3.904828,"marketCap":1553621318},{"date":"2022-09-02","current":-2.927877,"twenty":-18.431947,"median":-14.10667,"eighty":-3.545195,"marketCap":1491357868},{"date":"2022-09-09","current":-3.437199,"twenty":-18.422496,"median":-14.103623,"eighty":-3.451169,"marketCap":1750788909},{"date":"2022-09-16","current":-3.242201,"twenty":-18.414899,"median":-14.058044,"eighty":-3.370841,"marketCap":1651463882},{"date":"2022-09-23","current":-2.837654,"twenty":-18.402567,"median":-14.038583,"eighty":-3.306813,"marketCap":1445401512},{"date":"2022-09-30","current":-2.892952,"twenty":-18.38545,"median":-14.012905,"eighty":-3.236962,"marketCap":1473568311},{"date":"2022-10-07","current":-3.029741,"twenty":-18.366723,"median":-13.991375,"eighty":-3.229951,"marketCap":1543244076},{"date":"2022-10-14","current":-2.875489,"twenty":-18.362255,"median":-13.96778,"eighty":-3.214621,"marketCap":1464673532},{"date":"2022-10-21","current":-3.035562,"twenty":-18.359679,"median":-13.921816,"eighty":-3.17166,"marketCap":1546209002},{"date":"2022-10-28","current":-3.198545,"twenty":-18.35685,"median":-13.870509,"eighty":-3.161292,"marketCap":1629226935},{"date":"2022-11-04","current":-2.997162,"twenty":-18.345813,"median":-13.836853,"eighty":-3.129996,"marketCap":1470914038},{"date":"2022-11-11","current":-3.460138,"twenty":-18.3246,"median":-13.814206,"eighty":-3.104263,"marketCap":1698128402},{"date":"2022-11-18","current":-2.896647,"twenty":-18.312845,"median":-13.791224,"eighty":-3.093188,"marketCap":1421584604},{"date":"2022-11-25","current":-2.613379,"twenty":-18.311096,"median":-13.768935,"eighty":-3.082711,"marketCap":1282565289},{"date":"2022-12-02","current":-2.884464,"twenty":-18.306286,"median":-13.735517,"eighty":-3.057099,"marketCap":1415605278},{"date":"2022-12-09","current":-2.707802,"twenty":-18.292985,"median":-13.698738,"eighty":-3.038472,"marketCap":1328905061},{"date":"2022-12-16","current":-2.8205,"twenty":-18.2616,"median":-13.655724,"eighty":-3.022756,"marketCap":1384213820},{"date":"2022-12-23","current":-2.400166,"twenty":-18.250269,"median":-13.5957,"eighty":-3.011005,"marketCap":1177927095},{"date":"2022-12-30","current":-2.320973,"twenty":-18.229368,"median":-13.588886,"eighty":-2.983174,"marketCap":1139061481},{"date":"2023-01-06","current":-2.250917,"twenty":-18.22287,"median":-13.583977,"eighty":-2.971485,"marketCap":1104680360},{"date":"2023-01-13","current":-2.665159,"twenty":-18.209456,"median":-13.580361,"eighty":-2.926919,"marketCap":1307977422},{"date":"2023-01-20","current":-2.56769,"twenty":-18.202214,"median":-13.535005,"eighty":-2.907613,"marketCap":1260142819},{"date":"2023-01-27","current":-2.774811,"twenty":-18.189656,"median":-13.527444,"eighty":-2.896333,"marketCap":1361791350},{"date":"2023-02-03","current":-3.307843,"twenty":-18.183035,"median":-13.492717,"eighty":-2.894698,"marketCap":1623386835},{"date":"2023-02-10","current":-3.475367,"twenty":-18.156973,"median":-13.446485,"eighty":-2.896333,"marketCap":1705602558},{"date":"2023-02-17","current":-3.990124,"twenty":-18.132745,"median":-13.344804,"eighty":-2.896768,"marketCap":1958229055},{"date":"2023-02-24","current":-3.664917,"twenty":-18.127003,"median":-13.338568,"eighty":-2.899947,"marketCap":1763495962},{"date":"2023-03-03","current":-3.419541,"twenty":-18.104572,"median":-13.30953,"eighty":-2.90507,"marketCap":1645424988},{"date":"2023-03-10","current":-4.680888,"twenty":-18.07051,"median":-13.262445,"eighty":-2.907003,"marketCap":2252363830},{"date":"2023-03-17","current":-4.511098,"twenty":-18.064775,"median":-13.248215,"eighty":-2.909464,"marketCap":2170663577},{"date":"2023-03-24","current":-4.960543,"twenty":-18.058861,"median":-13.222467,"eighty":-2.915484,"marketCap":2386928952},{"date":"2023-03-31","current":-5.519853,"twenty":-18.051659,"median":-13.20999,"eighty":-2.925004,"marketCap":2656059196},{"date":"2023-04-06","current":-5.170284,"twenty":-18.049204,"median":-13.190521,"eighty":-2.92955,"marketCap":2487852794},{"date":"2023-04-14","current":-5.213564,"twenty":-18.039702,"median":-13.163935,"eighty":-2.936853,"marketCap":2508678348},{"date":"2023-04-21","current":-5.483231,"twenty":-18.008528,"median":-13.120004,"eighty":-2.945156,"marketCap":2638437573},{"date":"2023-04-28","current":-4.724168,"twenty":-17.996964,"median":-13.108081,"eighty":-2.969338,"marketCap":2273189385},{"date":"2023-05-05","current":-5.098963,"twenty":-17.978328,"median":-13.012532,"eighty":-2.972649,"marketCap":2166763486},{"date":"2023-05-12","current":-5.386016,"twenty":-17.960738,"median":-12.990726,"eighty":-2.974722,"marketCap":2288744245},{"date":"2023-05-19","current":-5.280259,"twenty":-17.943362,"median":-12.958206,"eighty":-2.976725,"marketCap":2243803966},{"date":"2023-05-26","current":-5.114071,"twenty":-17.928317,"median":-12.881958,"eighty":-2.980846,"marketCap":2173183526},{"date":"2023-06-02","current":-5.287813,"twenty":-17.89831,"median":-12.877744,"eighty":-2.983174,"marketCap":2247013986},{"date":"2023-06-09","current":-6.152749,"twenty":-17.895624,"median":-12.814449,"eighty":-2.997162,"marketCap":2614561273},{"date":"2023-06-16","current":-5.861919,"twenty":-17.88701,"median":-12.790369,"eighty":-3.003253,"marketCap":2490975504},{"date":"2023-06-23","current":-6.096093,"twenty":-17.84216,"median":-12.751575,"eighty":-3.008145,"marketCap":2590486123},{"date":"2023-06-30","current":-6.417139,"twenty":-17.809393,"median":-12.697254,"eighty":-3.014278,"marketCap":2726911973},{"date":"2023-07-07","current":-6.420916,"twenty":-17.792412,"median":-12.674549,"eighty":-3.01777,"marketCap":2728516983},{"date":"2023-07-14","current":-6.538004,"twenty":-17.787704,"median":-12.666883,"eighty":-3.018099,"marketCap":2778272292},{"date":"2023-07-21","current":-13.026906,"twenty":-17.752068,"median":-12.666883,"eighty":-3.019263,"marketCap":5535679455},{"date":"2023-07-28","current":-12.206209,"twenty":-17.694646,"median":-12.643182,"eighty":-3.024502,"marketCap":5186930808},{"date":"2023-08-04","current":-9.04402,"twenty":-17.681297,"median":-12.643228,"eighty":-3.032069,"marketCap":5182087735},{"date":"2023-08-11","current":-9.184326,"twenty":-17.667007,"median":-12.605139,"eighty":-3.035562,"marketCap":5262481003},{"date":"2023-08-18","current":-8.05578,"twenty":-17.651492,"median":-12.55478,"eighty":-3.036726,"marketCap":4615840855},{"date":"2023-08-25","current":-7.962207,"twenty":-17.643055,"median":-12.488397,"eighty":-3.038472,"marketCap":4562224963},{"date":"2023-09-01","current":-8.481111,"twenty":-17.638866,"median":-12.434869,"eighty":-3.042698,"marketCap":4859549454},{"date":"2023-09-08","current":-8.174872,"twenty":-17.633393,"median":-12.401532,"eighty":-3.049253,"marketCap":4684079263},{"date":"2023-09-15","current":-8.39888,"twenty":-17.624096,"median":-12.352952,"eighty":-3.051278,"marketCap":4812432458},{"date":"2023-09-22","current":-7.647461,"twenty":-17.620403,"median":-12.30172,"eighty":-3.057099,"marketCap":4381880601},{"date":"2023-09-29","current":-7.69283,"twenty":-17.613798,"median":-12.259147,"eighty":-3.061756,"marketCap":4407876184},{"date":"2023-10-06","current":-6.989615,"twenty":-17.611279,"median":-12.206209,"eighty":-3.063502,"marketCap":4004944635},{"date":"2023-10-13","current":-7.003793,"twenty":-17.6066,"median":-12.141084,"eighty":-3.072815,"marketCap":4013068255},{"date":"2023-10-20","current":-6.998122,"twenty":-17.588228,"median":-12.101539,"eighty":-3.082711,"marketCap":4009818807},{"date":"2023-10-27","current":-7.108708,"twenty":-17.566788,"median":-12.084826,"eighty":-3.083875,"marketCap":4073183042},{"date":"2023-11-03","current":-7.651953,"twenty":-17.537273,"median":-12.012885,"eighty":-3.085039,"marketCap":4687931013},{"date":"2023-11-10","current":-7.686814,"twenty":-17.526243,"median":-11.956547,"eighty":-3.088532,"marketCap":4709288097},{"date":"2023-11-17","current":-8.195103,"twenty":-17.510361,"median":-11.930684,"eighty":-3.094353,"marketCap":5020689120},{"date":"2023-11-24","current":-8.399555,"twenty":-17.494299,"median":-11.913139,"eighty":-3.097079,"marketCap":5145945398},{"date":"2023-12-01","current":-8.152509,"twenty":-17.469189,"median":-11.857337,"eighty":-3.104263,"marketCap":4994594062},{"date":"2023-12-08","current":-9.543916,"twenty":-17.429259,"median":-11.793812,"eighty":-3.115307,"marketCap":5847032617},{"date":"2023-12-15","current":-10.197026,"twenty":-17.381695,"median":-11.731234,"eighty":-3.121801,"marketCap":6247156837},{"date":"2023-12-22","current":-11.014832,"twenty":-17.355217,"median":-11.719248,"eighty":-3.129996,"marketCap":6748181947},{"date":"2023-12-29","current":-11.872393,"twenty":-17.354261,"median":-11.72602,"eighty":-3.131606,"marketCap":7273562444},{"date":"2024-01-05","current":-10.483826,"twenty":-17.341436,"median":-11.702268,"eighty":-3.143193,"marketCap":6422863559},{"date":"2024-01-12","current":-11.136935,"twenty":-17.32979,"median":-11.659423,"eighty":-3.152765,"marketCap":6822987779},{"date":"2024-01-19","current":-10.665561,"twenty":-17.326345,"median":-11.629086,"eighty":-3.155517,"marketCap":6534202473},{"date":"2024-01-26","current":-10.242459,"twenty":-17.321786,"median":-11.592759,"eighty":-3.161292,"marketCap":6274991565},{"date":"2024-02-02","current":-9.458728,"twenty":-17.298763,"median":-11.572263,"eighty":-3.166531,"marketCap":5794842502},{"date":"2024-02-09","current":-9.359342,"twenty":-17.266338,"median":-11.503758,"eighty":-3.167695,"marketCap":5733954033},{"date":"2024-02-16","current":-11.139775,"twenty":-17.227747,"median":-11.486207,"eighty":-3.17166,"marketCap":6824727449},{"date":"2024-02-23","current":-9.087803,"twenty":-17.158784,"median":-11.419175,"eighty":-3.176583,"marketCap":5845292947},{"date":"2024-03-01","current":-9.335554,"twenty":-17.077932,"median":-11.339868,"eighty":-3.183466,"marketCap":6004646954},{"date":"2024-03-08","current":-8.603155,"twenty":-17.056112,"median":-11.314907,"eighty":-3.185768,"marketCap":5533566780},{"date":"2024-03-15","current":-7.84321,"twenty":-17.050104,"median":-11.228386,"eighty":-3.189231,"marketCap":5044768381},{"date":"2024-03-22","current":-8.310648,"twenty":-17.043563,"median":-11.170649,"eighty":-3.201455,"marketCap":5345425509},{"date":"2024-03-28","current":-8.849779,"twenty":-17.040033,"median":-11.139775,"eighty":-3.213097,"marketCap":5692195694},{"date":"2024-04-05","current":-8.072628,"twenty":-17.037162,"median":-11.11833,"eighty":-3.216906,"marketCap":5192330161},{"date":"2024-04-12","current":-8.13285,"twenty":-16.996966,"median":-11.074422,"eighty":-3.224739,"marketCap":5231065129},{"date":"2024-04-19","current":-7.154958,"twenty":-16.991224,"median":-11.019807,"eighty":-3.227649,"marketCap":4602083038},{"date":"2024-04-26","current":-7.078422,"twenty":-16.989711,"median":-11.000634,"eighty":-3.233403,"marketCap":4552854895},{"date":"2024-05-03","current":-9.643939,"twenty":-16.978764,"median":-10.972094,"eighty":-3.23347,"marketCap":5190965672},{"date":"2024-05-10","current":-9.988117,"twenty":-16.973335,"median":-10.959651,"eighty":-3.242201,"marketCap":5376223639},{"date":"2024-05-17","current":-10.791199,"twenty":-16.9694,"median":-10.928667,"eighty":-3.256753,"marketCap":5808492230},{"date":"2024-05-24","current":-9.650892,"twenty":-16.924463,"median":-10.876468,"eighty":-3.271292,"marketCap":5194708257},{"date":"2024-05-31","current":-10.029835,"twenty":-16.892887,"median":-10.864916,"eighty":-3.280616,"marketCap":5398679151},{"date":"2024-06-07","current":-9.428393,"twenty":-16.866618,"median":-10.810296,"eighty":-3.285276,"marketCap":5074945531},{"date":"2024-06-14","current":-10.081983,"twenty":-16.844797,"median":-10.786611,"eighty":-3.287604,"marketCap":5426748540},{"date":"2024-06-21","current":-9.404057,"twenty":-16.814328,"median":-10.746489,"eighty":-3.296398,"marketCap":5061846483},{"date":"2024-06-28","current":-8.760896,"twenty":-16.75053,"median":-10.728734,"eighty":-3.300213,"marketCap":4715657352},{"date":"2024-07-05","current":-8.691365,"twenty":-16.630613,"median":-10.662018,"eighty":-3.300213,"marketCap":4678231500},{"date":"2024-07-12","current":-9.348432,"twenty":-16.450307,"median":-10.55255,"eighty":-3.300213,"marketCap":5031905801},{"date":"2024-07-15","current":-9.428393,"twenty":-16.387081,"median":-10.550062,"eighty":-3.300213,"marketCap":5074945531},{"date":"2024-08-02","current":-10.84727,"twenty":-15.904573,"median":-10.459746,"eighty":-3.282947,"marketCap":4922697080},{"date":"2024-08-09","current":-10.142902,"twenty":-15.794001,"median":-10.436937,"eighty":-3.282947,"marketCap":4603041426},{"date":"2024-08-16","current":-10.341782,"twenty":-15.720083,"median":-10.324027,"eighty":-3.282947,"marketCap":4693297140},{"date":"2024-08-23","current":-10.312779,"twenty":-15.554297,"median":-10.305383,"eighty":-3.282947,"marketCap":4680134848},{"date":"2024-08-30","current":-10.200908,"twenty":-15.468081,"median":-10.298317,"eighty":-3.282947,"marketCap":4629366009},{"date":"2024-09-06","current":-12.968661,"twenty":-15.406372,"median":-10.298317,"eighty":-3.282947,"marketCap":5885424699},{"date":"2024-09-13","current":-11.166307,"twenty":-15.373674,"median":-10.298317,"eighty":-3.282947,"marketCap":5067482289},{"date":"2024-09-20","current":-11.116587,"twenty":-15.373674,"median":-10.298317,"eighty":-3.282947,"marketCap":5044918360},{"date":"2024-09-27","current":-10.142902,"twenty":-15.346079,"median":-10.291437,"eighty":-3.282947,"marketCap":4603041426},{"date":"2024-10-04","current":-10.619386,"twenty":-15.346079,"median":-10.287903,"eighty":-3.282947,"marketCap":4819279074},{"date":"2024-10-11","current":-10.341782,"twenty":-15.346079,"median":-10.269126,"eighty":-3.282947,"marketCap":4693297140},{"date":"2024-10-18","current":-10.851413,"twenty":-15.346079,"median":-10.269126,"eighty":-3.282947,"marketCap":4924577408},{"date":"2024-10-25","current":-10.014458,"twenty":-15.346079,"median":-10.247312,"eighty":-3.282947,"marketCap":4544751277},{"date":"2024-10-31","current":-9.857011,"twenty":-15.346079,"median":-10.213164,"eighty":-3.282947,"marketCap":4473298837},{"date":"2024-11-08","current":-10.722969,"twenty":-15.348937,"median":-10.208384,"eighty":-3.280616,"marketCap":4866287259},{"date":"2024-11-15","current":-10.382683,"twenty":-15.348937,"median":-10.208384,"eighty":-3.280616,"marketCap":4556544126},{"date":"2024-11-22","current":-10.008028,"twenty":-15.271599,"median":-10.197026,"eighty":-3.280616,"marketCap":4392122998},{"date":"2024-11-29","current":-11.665984,"twenty":-15.218244,"median":-10.186868,"eighty":-3.280616,"marketCap":5119733736},{"date":"2024-12-06","current":-11.48081,"twenty":-15.156078,"median":-10.186868,"eighty":-3.280616,"marketCap":5038468121},{"date":"2024-12-13","current":-11.915754,"twenty":-15.091844,"median":-10.186868,"eighty":-3.280616,"marketCap":5229347821},{"date":"2024-12-20","current":-11.287023,"twenty":-14.973758,"median":-10.186868,"eighty":-3.280616,"marketCap":4953422710},{"date":"2024-12-27","current":-12.225813,"twenty":-14.909796,"median":-10.186868,"eighty":-3.280616,"marketCap":5365420478},{"date":"2025-01-03","current":-12.143992,"twenty":-14.881378,"median":-10.186868,"eighty":-3.280616,"marketCap":5329512416},{"date":"2025-01-10","current":-12.68229,"twenty":-14.811419,"median":-10.183098,"eighty":-3.278285,"marketCap":5565749668},{"date":"2025-01-17","current":-14.689063,"twenty":-14.775692,"median":-10.183098,"eighty":-3.278285,"marketCap":6446442146},{"date":"2025-01-24","current":-15.972364,"twenty":-14.759516,"median":-10.183098,"eighty":-3.278285,"marketCap":7009631756},{"date":"2025-01-31","current":-15.49005,"twenty":-14.759516,"median":-10.183098,"eighty":-3.278285,"marketCap":6797963177},{"date":"2025-02-07","current":-14.081863,"twenty":-14.698128,"median":-10.183098,"eighty":-3.278285,"marketCap":6179966525},{"date":"2025-02-14","current":-13.590936,"twenty":-14.67161,"median":-10.183098,"eighty":-3.278285,"marketCap":5964518151},{"date":"2025-02-21","current":-12.982947,"twenty":-14.658475,"median":-10.183098,"eighty":-3.278285,"marketCap":6955769662},{"date":"2025-02-28","current":-12.15831,"twenty":-14.555662,"median":-10.183098,"eighty":-3.278285,"marketCap":6513960440},{"date":"2025-03-07","current":-11.441236,"twenty":-14.509608,"median":-10.179327,"eighty":-3.275954,"marketCap":6129779415},{"date":"2025-03-14","current":-11.469635,"twenty":-14.509608,"median":-10.186868,"eighty":-3.275954,"marketCap":6144994506},{"date":"2025-03-21","current":-12.037614,"twenty":-14.509608,"median":-10.207344,"eighty":-3.275954,"marketCap":6449296307},{"date":"2025-03-28","current":-12.921532,"twenty":-14.509608,"median":-10.207344,"eighty":-3.275954,"marketCap":6922865986},{"date":"2025-04-04","current":-12.094412,"twenty":-14.509608,"median":-10.207344,"eighty":-3.275954,"marketCap":6479726487},{"date":"2025-04-11","current":-11.469635,"twenty":-14.509348,"median":-10.207864,"eighty":-3.278285,"marketCap":6144994506},{"date":"2025-04-17","current":-12.016315,"twenty":-14.509348,"median":-10.207864,"eighty":-3.278285,"marketCap":6437884990},{"date":"2025-04-25","current":-12.765338,"twenty":-14.509608,"median":-10.207344,"eighty":-3.275954,"marketCap":6839182990},{"date":"2025-05-02","current":-10.915822,"twenty":-14.487131,"median":-10.207344,"eighty":-3.275954,"marketCap":7291419648},{"date":"2025-05-09","current":-9.906677,"twenty":-14.440661,"median":-10.200908,"eighty":-3.275954,"marketCap":6617343092},{"date":"2025-05-16","current":-9.591141,"twenty":-14.390691,"median":-10.17585,"eighty":-3.275954,"marketCap":6406575492},{"date":"2025-05-23","current":-9.372256,"twenty":-14.253095,"median":-10.142902,"eighty":-3.275954,"marketCap":6260367338},{"date":"2025-05-30","current":-9.485963,"twenty":-14.231346,"median":-10.123196,"eighty":-3.275954,"marketCap":6336319626},{"date":"2025-06-06","current":-10.898766,"twenty":-14.231346,"median":-10.116749,"eighty":-3.275954,"marketCap":7280026804},{"date":"2025-06-13","current":-11.271155,"twenty":-14.231346,"median":-10.116749,"eighty":-3.275954,"marketCap":7528770548},{"date":"2025-06-20","current":-11.370648,"twenty":-14.232499,"median":-10.113252,"eighty":-3.273623,"marketCap":7595228800},{"date":"2025-06-27","current":-12.826091,"twenty":-14.224806,"median":-10.113252,"eighty":-3.273623,"marketCap":8567418086},{"date":"2025-07-03","current":-12.50487,"twenty":-14.224806,"median":-10.113252,"eighty":-3.273623,"marketCap":8352852872},{"date":"2025-07-11","current":-13.152997,"twenty":-14.224806,"median":-10.113252,"eighty":-3.273623,"marketCap":8785780914},{"date":"2025-07-18","current":-13.286602,"twenty":-14.224806,"median":-10.113252,"eighty":-3.273623,"marketCap":8875024852},{"date":"2025-07-25","current":-12.979594,"twenty":-14.224806,"median":-10.113252,"eighty":-3.273623,"marketCap":8669953675},{"date":"2025-08-01","current":-13.437263,"twenty":-14.224806,"median":-10.113252,"eighty":-3.273623,"marketCap":8975661634},{"date":"2025-08-08","current":-11.313785,"twenty":-14.224806,"median":-10.113252,"eighty":-3.273623,"marketCap":8784192758},{"date":"2025-08-15","current":-12.601513,"twenty":-14.224806,"median":-10.122691,"eighty":-3.273623,"marketCap":9784004034},{"date":"2025-08-22","current":-12.367605,"twenty":-14.224806,"median":-10.1284,"eighty":-3.273623,"marketCap":9602393955},{"date":"2025-08-29","current":-12.943758,"twenty":-14.224806,"median":-10.1284,"eighty":-3.273623,"marketCap":10049728255},{"date":"2025-09-05","current":-12.761556,"twenty":-14.227887,"median":-10.142902,"eighty":-3.271292,"marketCap":9908263562},{"date":"2025-09-12","current":-12.951145,"twenty":-14.224806,"median":-10.142902,"eighty":-3.273623,"marketCap":10055463310},{"date":"2025-09-19","current":-13.130885,"twenty":-14.211237,"median":-10.142902,"eighty":-3.273623,"marketCap":10195016318},{"date":"2025-09-26","current":-12.064755,"twenty":-14.211237,"median":-10.142902,"eighty":-3.273623,"marketCap":9367256696},{"date":"2025-10-03","current":-13.118574,"twenty":-14.211237,"median":-10.142902,"eighty":-3.273623,"marketCap":10185457893},{"date":"2025-10-10","current":-13.490366,"twenty":-14.205487,"median":-10.142902,"eighty":-3.273623,"marketCap":10474122334},{"date":"2025-10-14","current":-13.778443,"twenty":-14.205487,"median":-10.142902,"eighty":-3.273623,"marketCap":10697789483}],"updateTime":1760566498328},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BBIO\",pageSize:20,pageCount:4,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2557311740","title":"BridgeBio Pharma Inc - Fortify Phase 3 Topline Results Expected Fall 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2557311740","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2557311740?lang=en_us&edition=fundamental","pubTime":"2025-08-06 04:01","pubTimestamp":1754424061,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250805:nPLX6E7D08:6","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BBIO","BK4505","BK4588","BK4139","BK4585"],"gpt_icon":0},{"id":"2557311722","title":"BridgeBio Pharma Inc - Propel 3 Phase 3 Topline Results Expected Early 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2557311722","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2557311722?lang=en_us&edition=fundamental","pubTime":"2025-08-06 04:01","pubTimestamp":1754424061,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250805:nPLX6E7D08:7","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4588","BBIO","BK4505","BK4139","BK4585"],"gpt_icon":0},{"id":"2557148393","title":"Corrected-BridgeBio Pharma Q2 Revenue USD 110.6 Million VS. Ibes Estimate USD 91.4 Million (Corrects Amount)","url":"https://stock-news.laohu8.com/highlight/detail?id=2557148393","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2557148393?lang=en_us&edition=fundamental","pubTime":"2025-08-06 04:01","pubTimestamp":1754424061,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250805:nPLX6E7D08:8","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4505","BK4139","BK4588","BK4585","BBIO"],"gpt_icon":0},{"id":"2557805334","title":"Helix Acquisition Corp. II Conducted Extraordinary General Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2557805334","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2557805334?lang=en_us&edition=fundamental","pubTime":"2025-08-05 04:46","pubTimestamp":1754340393,"startTime":"0","endTime":"0","summary":"Helix Acquisition Corp. II held an extraordinary general meeting on August 4, 2025. During the meeting, shareholders voted on several proposals. The Business Combination Proposal, which involved the entry into the Business Combination Agreement with TheRas, Inc., was approved. Additionally, the Stock Issuance Proposal, related to the issuance of shares to Helix and BBOT shareholders as well as PIPE Investors, was also approved.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Helix Acquisition Corp. II published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on August 04, 2025, and is solely responsibl","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250804:nNDL46Gp6Z:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BBIO","BK4585","BK4588","HLXB","BK4139","BK4505"],"gpt_icon":0},{"id":"2555986025","title":"Biotech Has Been Stalling. 3 Stocks That Could See Healthy Gains. -- Barrons.com","url":"https://stock-news.laohu8.com/highlight/detail?id=2555986025","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2555986025?lang=en_us&edition=fundamental","pubTime":"2025-07-31 00:37","pubTimestamp":1753893420,"startTime":"0","endTime":"0","summary":"The biotech sector is facing a pivotal moment, after a frustrating year of stalled rallies.A look at the widely followed industry benchmark SPDR S&P Biotech exchange-traded fund  shows just how frustrating price action has been for investors so far in 2025. The 200-day simple moving average -- a line which many professional traders use to determine the genuine health of the instrument -- has repeatedly acted as a stubborn ceiling. It has rejected the fund's advances throughout January, February, and now again in July, with the line trending downward.Yet, technical signals offer bulls some hope: The ETF has seen a series of higher lows since early April and the current retest of a breakout above a short-lived cup base formed between June and July. Biotech's next move from here could set the tone for the rest of the year.The SPDR S&P Biotech ETF traded at $87.20 Wednesday.Specific winners within SPDR S&P Biotech could help the fund break higher. While the sector often splits between lead","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0320765992.SGD","INSM","BK4581","IE0002141913.USD","BBIO","LU2089984988.USD","BK4585","LU2242652126.USD","LU1983299246.USD","LU0868494617.USD","AMGN","IE00BJT1NW94.SGD","BK4599","IE00B4R5TH58.HKD","LU1057294990.SGD","IE00B2B36J28.USD","BK4533","IE0009355771.USD","IE00BJJMRZ35.SGD","LU0289739699.SGD","LU1061106388.HKD","BK4534","IE00BFTCPJ56.SGD","LU2112291526.USD","LU2468319806.SGD","LU0058720904.USD","BK4505","LU2242646821.SGD","LU1023059063.AUD","LU0109394709.USD","BK4588","LU0053671581.USD","LU0889565916.HKD","SG9999001440.SGD","BK4139","LU1571399168.USD","LU0122379950.USD","BK4566"],"gpt_icon":0},{"id":"2553217760","title":"BRIEF-Novel Human Genetics Evidence Confirms Estimates Of Genetic Prevalence, Underdiagnosis, And Potentially Greater Symptom Burden Of Gain-Of-Function CASR Variants Associated With ADH1","url":"https://stock-news.laohu8.com/highlight/detail?id=2553217760","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2553217760?lang=en_us&edition=fundamental","pubTime":"2025-07-23 19:44","pubTimestamp":1753271070,"startTime":"0","endTime":"0","summary":"BRIEF-Novel Human Genetics Evidence Confirms Estimates Of Genetic Prevalence, Underdiagnosis, And Potentially Greater Symptom Burden Of Gain-Of-Function CASR Variants Associated With ADH1July 23 (Reut","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250723:nTUA9QYTBS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BBIO","BK4585","BK4588","BK4139","BK4505"],"gpt_icon":0},{"id":"2553176792","title":"BridgeBio Pharma Announces Full Enrollment of Phase 3 Trial for Encaleret, Aiming to Address Underdiagnosed ADH1 Disorder","url":"https://stock-news.laohu8.com/highlight/detail?id=2553176792","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2553176792?lang=en_us&edition=fundamental","pubTime":"2025-07-23 19:30","pubTimestamp":1753270239,"startTime":"0","endTime":"0","summary":"BridgeBio Pharma Inc. has announced the full enrollment of 71 participants in its Phase 3 clinical trial, CALIBRATE, which is evaluating encaleret for the treatment of autosomal dominant hypocalcemia type 1 . This trial is the largest prospective interventional study ever conducted for ADH1. BridgeBio expects to report topline results in the second half of 2025. If successful, encaleret could become the first approved therapy for individuals with ADH1. Additionally, the company plans to initiate a registrational study of encaleret in chronic hypoparathyroidism in 2026. This follows the publication of an analysis in the American Journal of Human Genetics, which confirmed prior estimates of the genetic prevalence of ADH1 and highlighted the underdiagnosis of the condition.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational pur","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250723:nNDL8L0g3K:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BBIO","NDAQ","BK4585","IE00B64PRP62.GBP","IE00BGHQF748.EUR","LU2210150020.SGD","IE00B3QW5Z07.USD","BK4505","LU2210149790.SGD","BK4588","BK4139","IE00BKPKM429.USD","LU2095319765.USD","BK4112"],"gpt_icon":0},{"id":"2553584872","title":"BridgeBio Pharma Inc. to Release Second Quarter 2025 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2553584872","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2553584872?lang=en_us&edition=fundamental","pubTime":"2025-07-22 19:30","pubTimestamp":1753183812,"startTime":"0","endTime":"0","summary":"Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. BridgeBio Pharma Inc. published the original content used to generate this news brief via GlobeNewswire  on July 22, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250722:nNDL7QkHMG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2095319765.USD","LU2210150020.SGD","IE00B3QW5Z07.USD","BK4505","BK4112","BK4139","BK4588","BK4585","IE00BGHQF748.EUR","IE00BKPKM429.USD","BBIO","IE00B64PRP62.GBP","NDAQ","LU2210149790.SGD"],"gpt_icon":0},{"id":"2553471121","title":"Truist Securities Initiates Coverage on BridgeBio Pharma With Buy Rating, $66 Price Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2553471121","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2553471121?lang=en_us&edition=fundamental","pubTime":"2025-07-21 20:06","pubTimestamp":1753099569,"startTime":"0","endTime":"0","summary":"BridgeBio Pharma (BBIO) has an average rating of Buy and mean price target of $62.48, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major ba","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BBIO"],"gpt_icon":0},{"id":"2551136313","title":"BridgeBio Pharma Inc. Publishes Document on CLARIFY Study of ADH1/2 Disease Monitoring","url":"https://stock-news.laohu8.com/highlight/detail?id=2551136313","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2551136313?lang=en_us&edition=fundamental","pubTime":"2025-07-15 04:55","pubTimestamp":1752526535,"startTime":"0","endTime":"0","summary":"BridgeBio Pharma Inc. published a document on the CLARIFY disease monitoring study, which is a global, multicenter, longitudinal, non-interventional study. The study aims to understand the disease burden, management, and progression in pediatric and adult participants with Autosomal Dominant Hypocalcemia Types 1 and 2  over five years. The document includes details on the study design, methods, and baseline characteristics of pediatric participants. The full document can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. BridgeBio Pharma Inc. published the original content used to generate this news brief on July 15, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250714:nNDL46N6ln:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4585","BK4588","BK4505","BBIO"],"gpt_icon":0},{"id":"2551186343","title":"BridgeBio Pharma Initiated at Buy by Jefferies","url":"https://stock-news.laohu8.com/highlight/detail?id=2551186343","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2551186343?lang=en_us&edition=fundamental","pubTime":"2025-07-14 19:32","pubTimestamp":1752492720,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/BBIO/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  July 14, 2025 07:32 ET (11:32 GMT)","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BBIO","BK4585","BK4505","BK4139","BK4588"],"gpt_icon":0},{"id":"2551590850","title":"U.S. RESEARCH ROUNDUP-Best Buy, Chevron, SoundHound AI","url":"https://stock-news.laohu8.com/highlight/detail?id=2551590850","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2551590850?lang=en_us&edition=fundamental","pubTime":"2025-07-14 15:51","pubTimestamp":1752479493,"startTime":"0","endTime":"0","summary":"U.S. RESEARCH ROUNDUP-Best Buy, Chevron, SoundHound AIJuly 14 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Best Buy, ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250714:nL4N3TB0J6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SOUN","HLI","NDAQ","TWLO","KNSL","IE00B7KXQ091.USD","BK4227","ALLY","BFH","SYF","DASH","LU0630314457.HKD","MC","LAZ","RYAN","HD","CBOE","PGR","BBIO","WEX","KLG","LEVI","SNEX","BBY","PWP","ALL","BK4548","COF","OTIS","AXP","CVX","CF","HIG","FI","IE00B775H168.HKD","SLDE","ICE","IE00BQXX3F31.USD","AIG","XYZ","HGTY","LOW","TRV","PJT","LW","EVR","CME","GSHD"],"gpt_icon":1},{"id":"2551928638","title":"BridgeBio Pharma Inc. Publishes Document on Phase 2/3 Study of Encaleret for Autosomal Dominant Hypocalcemia Type 1 in Pediatrics","url":"https://stock-news.laohu8.com/highlight/detail?id=2551928638","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2551928638?lang=en_us&edition=fundamental","pubTime":"2025-07-14 03:15","pubTimestamp":1752434145,"startTime":"0","endTime":"0","summary":"BridgeBio Pharma Inc. Publishes Document on Phase 2/3 Study of Encaleret for Autosomal Dominant Hypocalcemia Type 1 in Pediatrics. BridgeBio Pharma Inc. published a document detailing the CALIBRATE-PEDS Phase 2/3 study design for Encaleret, an investigational oral negative allosteric modulator of the calcium-sensing receptor. The study evaluates the pharmacokinetics, efficacy, and safety of Encaleret in pediatric participants with Autosomal Dominant Hypocalcemia Type 1 . The document includes key eligibility criteria, primary endpoints, additional health parameters assessed, and exclusion criteria for study participants. The full document can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. BridgeBio P","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250713:nNDL9vVLxf:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","BK4585","BBIO","BK4139","BK4505"],"gpt_icon":0},{"id":"2551806919","title":"BridgeBio Pharma Inc. Publishes Findings on Genetic Contributors of Non-Surgical Hypoparathyroidism","url":"https://stock-news.laohu8.com/highlight/detail?id=2551806919","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2551806919?lang=en_us&edition=fundamental","pubTime":"2025-07-13 03:28","pubTimestamp":1752348538,"startTime":"0","endTime":"0","summary":"Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. BridgeBio Pharma Inc. published the original content used to generate this news brief on July 12, 2025, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250712:nNDL335nD6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4505","BK4585","BK4139","BK4588","BBIO"],"gpt_icon":0},{"id":"2550966568","title":"BridgeBio Pharma Is Maintained at Buy by Citigroup","url":"https://stock-news.laohu8.com/highlight/detail?id=2550966568","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2550966568?lang=en_us&edition=fundamental","pubTime":"2025-07-12 03:04","pubTimestamp":1752260640,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/BBIO/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  July 11, 2025 15:04 ET (19:04 GMT)","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BBIO"],"gpt_icon":0},{"id":"2550656372","title":"BridgeBio Pharma May Keep Outperforming as Attruby Sales Beat Consensus, Oppenheimer Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2550656372","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2550656372?lang=en_us&edition=fundamental","pubTime":"2025-07-09 22:34","pubTimestamp":1752071699,"startTime":"0","endTime":"0","summary":"BridgeBio Pharma  is likely to see a continuation of its share outperformance as sales of Attruby, its FDA-approved treatment for transthyretin amyloid cardiomyopathy, beat consensus estimates, Oppenheimer said in a note Wednesday.The investment firm said its Attruby Q2 and full-year sales estimates of $76 million and $374 million are \"well above\" consensus forecasts and may even \"prove conservative given our assumptions around flat monthly script growth and high rates of free scripts.\"Oppenheimer also expects BridgeBio's \"commercial success to be compounded by positive clinical results from ADH1 and LGMD2i clinical trials\" around the end of the year.The firm said it still has some concerns related to \"long-term revenue durability,\" but the company has time to show \"real-world datasets demonstrating benefit over tafamidis should generics become available in 2029.\"Meanwhile, BridgeBio also faces some risks linked to ongoing tafamidis PTE litigation, but \"timelines suggest earliest resol","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate","earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["03650","BBIO","OPY"],"gpt_icon":0},{"id":"2548387199","title":"BridgeBio Pharma CEO Neil Kumar Reports Disposal of Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2548387199","media":"Reuters","labels":["shareholding","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2548387199?lang=en_us&edition=fundamental","pubTime":"2025-07-04 04:31","pubTimestamp":1751574673,"startTime":"0","endTime":"0","summary":"Neil Kumar, Chief Executive Officer of BridgeBio Pharma Inc., reported a disposal of common shares of the company. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. BridgeBio Pharma Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on July 03, 2025, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250703:nNDL7m0hzr:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","BK4588","BK4139","BBIO","BK4505"],"gpt_icon":0},{"id":"2548898271","title":"BridgeBio Pharma Inc. Enters $300 Million Royalty Financing Agreement with Acoramidis Royalty SPV, LP and LSI Financing Fund, LP","url":"https://stock-news.laohu8.com/highlight/detail?id=2548898271","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2548898271?lang=en_us&edition=fundamental","pubTime":"2025-07-02 18:00","pubTimestamp":1751450456,"startTime":"0","endTime":"0","summary":"BridgeBio Pharma Inc. Enters $300 Million Royalty Financing Agreement with Acoramidis Royalty SPV, LP and LSI Financing Fund, LP. BridgeBio Pharma Inc. has entered into a significant financial agreement involving the sale of royalty interests. On June 27, 2025, BridgeBio and its subsidiary Eidos Therapeutics, Inc. finalized a Royalty Interest Purchase and Sale Agreement with Acoramidis Royalty SPV, LP and LSI Financing Fund, LP. This agreement involves Eidos selling certain royalty payment rights from net sales of products containing acoramidis in the European Union and related territories. In exchange, the purchasers have agreed to pay Eidos $300 million in cash. The purchasers' rights are capped annually at 60% of royalty payments from Bayer and include an initial hard cap of 145% of the purchase price. This arrangement is secured by specific assets and includes standard representations, warranties, and indemnification obligations.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250702:nNDL2Tj67S:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","BK4505","BK4585","BK4139","BBIO"],"gpt_icon":0},{"id":"2548835789","title":"Viking Global Investors LP Reports Disposal of Common Shares of BridgeBio Pharma Inc","url":"https://stock-news.laohu8.com/highlight/detail?id=2548835789","media":"Reuters","labels":["shareholding","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2548835789?lang=en_us&edition=fundamental","pubTime":"2025-07-02 07:49","pubTimestamp":1751413766,"startTime":"0","endTime":"0","summary":"Viking Global Investors LP, a beneficial owner, reported a disposal of common shares of BridgeBio Pharma Inc. [BBIO]. The filing was made by more than one reporting person, including Scott M. Hendler on behalf of Mr. Halvorsen, Mr. Ott, and Ms. Shabet, along with other reporting beneficial owners. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. BridgeBio Pharma Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on July 01, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250701:nNDL8j4bJb:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BBIO","BK4588","BK4505","BK4139","BK4585"],"gpt_icon":0},{"id":"2548004343","title":"Director Hannah Valantine Reports Disposal of Common Shares in BridgeBio Pharma Inc","url":"https://stock-news.laohu8.com/highlight/detail?id=2548004343","media":"Reuters","labels":["shareholding","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2548004343?lang=en_us&edition=fundamental","pubTime":"2025-07-01 05:52","pubTimestamp":1751320341,"startTime":"0","endTime":"0","summary":"Hannah A. Valantine, a Director at BridgeBio Pharma Inc., reported a disposal of common shares of the company. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. BridgeBio Pharma Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on June 30, 2025, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250630:nNDLjqpwk:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","BBIO","BK4505","BK4139","BK4588"],"gpt_icon":0}],"pageSize":20,"totalPage":6,"pageCount":4,"totalSize":111,"code":"91000000","status":"200"}]}}